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Background-—The predictive value of coronary artery calcium (CAC) has been widely studied; however, little is known about
speciﬁc characteristics of CAC that are most predictive. We aimed to determine the independent associations of Agatston score,
CAC volume, CAC area, CAC mass, and CAC density score with major adverse cardiac events in patients with suspected coronary
artery disease.
Methods and Results-—A total of 379 symptomatic participants, aged 45 to 85 years, referred for invasive coronary angiography,
who underwent coronary calcium scanning and computed tomography angiography as part of the CORE320 (Combined
Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography) study, were
included. Agatston score, CAC volume, area, mass, and density were computed on noncontrast images. Stenosis measurements
were made on contrast-enhanced images. The primary outcome of 2-year major adverse cardiac events (30 revascularizations
[>182 days of index catheterization], 5 myocardial infarctions, 1 cardiac death, 9 hospitalizations, and 1 arrhythmia) occurred in 32
patients (8.4%). Associations were estimated using multivariable proportional means models. Median age was 62 (interquartile
range, 56–68) years, 34% were women, and 56% were white. In separate models, the Agatston, volume, and density scores were all
signiﬁcantly associated with higher risk of major adverse cardiac events after adjustment for age, sex, race, and statin use; density
was the strongest predictor in all CAC models. CAC density did not provide incremental value over Agatston score after adjustment
for diameter stenosis, age, sex, and race.
Conclusions-—In symptomatic patients, CAC density was the strongest independent predictor of major adverse cardiac events
among CAC scores, but it did not provide incremental value beyond the Agatston score after adjustment for diameter stenosis.
( J Am Heart Assoc. 2019;8:e007201 DOI: 10.1161/JAHA.117.007201)
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I n patients, risk stratiﬁcation of cardiovascular disease andcoronary heart disease is critical for determining clinical
management. Coronary artery calcium (CAC) is a component
of atherosclerosis almost solely found in atherosclerotic
arteries.1 Measured by noncontrast cardiac-gated computed
tomography (CT), CAC has proved to be an important
subclinical predictor of incident cardiovascular disease2 and
scoring of CAC is considered one of the best subclinical
cardiovascular disease measures for risk prediction of
cardiovascular events.1,3,4 Together with traditional risk
factors, CAC scoring can be used to calculate an accurate
estimate of the 10-year coronary heart disease risk.5
Conversely, absence of CAC is associated with good
prognosis.2,4,6–10 Although mostly performed in asymptomatic
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individuals, there is evidence that CAC scoring also has
prognostic value in symptomatic populations.11–14
Assessment of the extent of CAC is of importance for
prediction as well as for diagnostic and therapeutic
considerations.15 Beyond the Agatston calcium score, other
characteristics, such as the calcium area, volume, mass, and
density of plaques in coronary arteries, can be obtained from
coronary calcium scanning.16 Several studies have shown
associations between CAC density and risk of cardiovascular
events17 and mortality.17,18 However, little is known about the
predictive value of speciﬁc characteristics of CAC in symp-
tomatic individuals. The aim of this study is to determine to
what extent these speciﬁc CAC characteristics are associated
with major adverse cardiac events (MACEs) in symptomatic
individuals suspected of having coronary artery disease (CAD).
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Study Participants
Symptomatic individuals, aged 45 to 85 years, referred for
clinically driven invasive coronary angiography (ICA) for
suspected or known CAD, were enrolled at 16 sites in 8
countries in the prospective, multicenter, international
CORE320 (Combined Noninvasive Coronary Angiography
and Myocardial Perfusion Imaging Using 320 Detector
Computed Tomography) study (http://www.clinicaltrials.gov,
NCT00934037). This trial examined the diagnostic accuracy
of combined 320-row CT angiography (CTA) and myocardial
CT perfusion imaging in comparison to the combination of ICA
and single-photon emission CT myocardial perfusion imaging.
The study design and CT methods have been previously
reported.19,20 All participants underwent a CAC scan and
cardiac CTA before clinically indicated ICA. Informed consent
was given by all patients, and the study was approved by the
institutional review boards of all participating sites.
CT Acquisition
A detailed description of the CT acquisition and the interpre-
tation methods has been previously published.19 In brief, a
noncontrast cardiac CT scan was performed before the CTA on
a 32090.5-mm detector row CT system (Aquilion ONE; Toshiba
Medical Systems, Otawara, Japan). For CAC measurements,
noncontrast cardiac CT scans were performed using prospec-
tive ECG triggering over a single heartbeat with a gantry
rotation and x-ray exposure time of 0.35 seconds and 0.5-mm
slice collimation. The CTA scan was performed using prospec-
tive triggering. All images were reconstructed in a centralized
core laboratory and interpreted in a blinded core laboratory.
Coronary calcium quantiﬁcation
Coronary atherosclerotic calcium quantiﬁcation
In the noncontrast scan, Agatston score and CAC volume
were measured on a commercially available CT workstation
(Vitrea, FX version 3.0 workstation; Vital Images, Minnetonka,
MN). We computed scores for Agatston, volume, area, mass,
and density (Figure).
1. The Agatston score was computed using standard
methods.1
2. The volume score was computed as the sum of the total
volume of calcium of the calciﬁed regions in all vessels.
The actual volume score measure, ﬁrst introduced by
Callister et al,21 is 1/1000th of a cubic centimeter;
however, it is artiﬁcially multiplied by 1000 to make it
more comparable to the Agatston score.
3. The area score was computed by dividing the calcium
volume score by the reconstruction slice thickness of
3 mm.
4. The mass score was computed on the Vitrea workstation
using standard methods with a calibration factor of 0.838.16
5. The mean density score was computed by dividing the
Agatston score by the area score.17
Clinical Perspective
What Is New?
• In our symptomatic population referred for coronary
angiography, Agatston score, calcium volume score, and
calcium density score are signiﬁcant and independent
predictors of incident 2-year major adverse cardiac events.
• Calcium density is superior to Agatston and calcium volume
scoring, but it did not provide incremental value beyond the
Agatston score after adjustment for diameter stenosis.
What Are the Clinical Implications?
• Evaluation of speciﬁc characteristics of coronary artery
calcium (CAC), such as the calcium density score, may be of
signiﬁcance when evaluating current CAC scoring systems
and assessing the role of CAC scores in coronary heart
disease risk prediction models.
• Further research into associations between CAC scores and
cardiac events, as well as the incremental value of speciﬁc
CAC characteristics beyond the Agatston score in coronary
heart disease risk prediction, is necessary to assess how
broader CAC scoring may enhance risk prediction of cardiac
events.
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Major Adverse Cardiac Events
The primary outcome was time to MACEs at 2 years. MACE
was deﬁned as a composite of the occurrence of myocardial
infarction, cardiac death, hospitalization for chest pain or
congestive heart failure, arrhythmia, and late revascularization
(beyond 182 days of the index ICA). Events were ascertained
at 30 days, 6 months, 12 months, and 24 months after
enrollment. Follow-up data were acquired through ofﬁce visits,
telephone interviews, and medical record review using a
standardized questionnaire. A panel of 9 physicians adjudi-
cated the reported events. For adjudication, non-English
medical records were translated to English. Twenty-one had 1
MACE, and 11 patients had 1 or 2 repeated events.
Statistical Analysis
Spearman correlation coefﬁcients were used to describe the
associations between Agatston, volume, area, mass, and
density scores. Agatston, volume, area, and mass scores were
modelled as natural logarithms (log [score+1]) because of
their right-skewed distributions. The addition of 1 to the
calcium score before logarithmic transformation allowed us to
include all patients with a calcium score of 0 in the analyses.
All predictors were then rescaled by dividing by their SD to
facilitate interpretation of the results. Three proportional
means models with a robust variance estimate were used to
quantify the independent associations of CAC scores (Agat-
ston, volume, area, mass, and density scores) and diameter
Figure. An illustration of 2 cases with comparable Agatston scores and different coronary artery calcium
(CAC) density scores. Panel 1 depicts cardiac computed tomographic images, showing low-density calciﬁed
plaque of a 44-year-old symptomatic man, with a body mass index of 26.5 kg/m2, referred for invasive
angiography for suspected coronary artery disease. The Agatston score and CAC density score are 113 and
1.67, respectively. Panel 1 includes stented segments that were not calculated as part of the coronary
calcium score. Panel 2 depicts similar images of a 64-year-old symptomatic woman, with a body mass index
of 24.8 kg/m2, with high-density calciﬁed plaque, yielding an Agatston score of 107 and a CAC density
score of 3.57. A, The left coronary circulation. B, The right coronary circulation.
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stenosis with recurrent MACEs. The ﬁrst model was unad-
justed. Potential confounding effects of age, sex, and race
were accounted for in the second model, and the third model
additionally included baseline statin use. In addition, a
sensitivity analysis excluding patients with a CAC score of 0
was performed, using the same proportional means models.
The incremental value of density and diameter stenosis above
Agatston score to predict time to MACEs was evaluated using
nested proportional means models, adjusting for age, sex, and
race. Again, a sensitivity analysis excluding patients with a
Table 1. Baseline Characteristics
Characteristics All (N=379)
Agatston Calcium Score
0 (N=64) 1–100 (N=93) 101–399 (N=100) ≥400 (N=121)
Age, y 62.0 (55.6–68.4) 57.6 (51.6–61.8) 60.8 (54.4–67.8) 63.5 (58.3–68.4) 63.5 (57.9–71.2)
Male sex 252 (66.5) 27 (42.2) 49 (52.7) 75 (75.0) 100 (82.6)
Race
White 216 (56.2) 37 (57.8) 52 (55.9) 54 (54.0) 69 (57.0)
Black 39 (10.3) 12 (18.8) 12 (12.9) 7 (7.0) 8 (6.6)
Asian 123 (32.5) 14 (21.9) 29 (31.2) 37 (37.0) 43 (35.5)
Other 4 (1.1) 1 (1.6) 2 (2.0) 1 (0.8)
Clinical characteristics
Body mass index, kg/m2 26.6 (24.1–30.1) 26.6 (24.2–30.5) 27.1 (24.6–30.3) 26.2 (23.9–28.9) 26.6 (24.2–30.1)
Hypertension 295 (78.2) 34 (54.8) 74 (79.6) 84 (84.0) 102 (84.3)
Diabetes mellitus 130 (34.3) 16 (25.0) 32 (34.4) 35 (35.0) 46 (38.0)
Dyslipidemia 252 (67.9) 32 (50.0) 58 (64.4) 68 (69.4) 93 (78.8)
Previous myocardial infarction 103 (27.2) 8 (12.5) 30 (32.3) 28 (28.0) 37 (30.6)
Statin use 204 (68.7) 33 (67.4) 42 (59.2) 54 (68.4) 74 (77.3)
Smoking
Current 62 (17.1) 11 (17.2) 13 (14.8) 21 (22.6) 17 (14.7)
Former 133 (36.7) 19 (29.7) 32 (36.4) 35 (37.6) 46 (39.7)
Never 167 (46.1) 34 (53.1) 43 (48.9) 37 (39.8) 53 (45.7)
Family history of CAD 161 (45.2) 25 (39.1) 32 (37.2) 45 (46.4) 58 (53.7)
Prior PCI 113 (29.8) 7 (10.9) 29 (31.2) 32 (32.0) 45 (37.2)
History of unstable angina 27 (7.3) 3 (4.8) 4 (4.4) 6 (6.0) 14 (12.0)
Angina (30 d), Canadian class
0 62 (21.5) 19 (34.5) 17 (25.4) 14 (17.3) 12 (14.3)
1 110 (38.2) 23 (41.8) 28 (41.8) 28 (34.6) 31 (36.9)
2 98 (34.0) 13 (23.6) 17 (25.4) 32 (39.5) 35 (41.7)
3 14 (4.9) 4 (6.0) 6 (7.4) 4 (4.8)
4 4 (1.4) 1 (1.5) 1 (1.2) 2 (2.4)
Scores
Agatston 162 (9–548) 0 (0–0) 18 (5–54) 214 (154–295) 865 (559–1420)
Volume 159 (11–472) 0 (0–0) 23 (9–58) 203 (145–274) 767 (484–1153)
Area 53 (4–157) 0 (0–0) 8 (3–19) 68 (48–91) 256 (161–384)
Mass 34 (2–109) 0 (0–0) 4 (1–11) 45 (29–61) 178 (114–301)
Density 3 (2–4) 0 (0–0) 2 (2–3) 3 (3–4) 4 (3–4)
Stenosis, % 62 (41–89) 36 (15–42) 43 (35–58) 71 (52–93) 87 (67–100)
MACEs per 1000 patient-years 44.9 (31.7–63.4) 16.2 (4.0–64.7) 33.7 (15.1–74.9) 58.6 (32.5–105.9) 58.7 (34.1–101.0)
Values are number (percentage) or median (interquartile range). CAD indicates coronary artery disease; MACE, major adverse cardiac event; PCI, percutaneous coronary intervention.
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negative CAC score was performed. Proportionality of hazards
was tested in all models, and all P values were >0.30. All
hazard ratios models reﬂected 1-SD difference in the main
exposures. Statistical analyses were performed using SAS,
version 9.4 (SAS Institute, Cary, NC). All tests were 2 sided,
and P<0.05 was considered statistically signiﬁcant.
Results
All 379 patients completed follow-up, underwent CAC scan-
ning and CTA, and were available for the analysis. The median
age of the population was 62 years (interquartile range [IQR],
56–68 years), 34% were women, 56% were white, 33% were
Asian, and 10% were black (Table 1). Agatston CAC score >0
was found in 314 patients. Median Agatston score was 162
units (IQR, 9–548 units), median volume score was 159 (IQR,
11–472), median area score was 53 (IQR, 4–157), median
mass score was 34 (IQR, 2–109), and median density score
was 3 (IQR, 2–4). A total of 46 cases of MACEs occurred in 32
of the 379 participants included (8.4%), of which 30 were
revascularizations beyond 182 days of the index ICA, 5 were
myocardial infarctions, 1 was a cardiac death, 1 was a
hospitalization for congestive heart failure, 8 were hospital-
izations for chest pain, and 1 was a case of arrhythmia. Eight
patients experienced 2 MACEs, and 3 experienced a total of 3
MACEs over 2 years of follow-up.
CAC Scores and Diameter Stenosis as Predictors
of MACEs
All CAC scores (Agatston, volume, area, mass, and density)
were strongly correlated, with r>0.80 for correlations between
calcium density and the other scores and r>0.99 for
correlations between Agatston, volume, area, and mass
scores (Table 2). In unadjusted models, Agatston score,
CAC volume, CAC area, CAC mass, density score, and
diameter stenosis were all signiﬁcant independent predictors
of MACEs, with diameter stenosis being the strongest
predictor (Table 3). In models adjusted for age, sex, and
race, the Agatston score, density score, and diameter
stenosis were signiﬁcant predictors of MACEs, with CAC
density being the strongest predictor among the CAC scores,
with a hazard ratio of 1.70 (95% conﬁdence interval [CI],
1.09–2.65) compared with Agatston score, with a hazard ratio
of 1.45 (95% CI, 0.99–2.10) (model 1, Table 3). After a further
adjustment for statin use (model 2), CAC density remained
the strongest predictor of MACEs among CAC scores. The
strongest overall predictor of MACEs in the adjusted models
(models 1 and 2) was diameter stenosis. In the sensitivity
analysis excluding patients with a CAC score of 0, the
associations between CAC scores (Agatston, volume, area,
mass, and density) and MACEs remained positive, but were no
longer signiﬁcant (Table 4).
Incremental Value of CAC Density and Diameter
Stenosis Above Agatston Score in Predication of
MACEs
Agatston score was a signiﬁcant predictor of MACEs in
symptomatic patients after adjustment for age, sex, and race,
with a hazard ratio of 1.45 (95% CI, 0.99–2.10); however, this
Table 2. Spearman Correlation for the 5 CAC Scores
Score
ln
(Agatston)
ln
(Volume)
ln
(Area) Density
ln
(Mass)
ln
(Agatston)
1.00 0.997 0.998 0.832 0.998
ln (Volume) 1.00 1.00 0.800 0.996
ln (Area) 1.00 0.800 0.996
Density 1.00 0.835
ln (Mass) 1.00
CAC indicates coronary artery calcium; ln, natural logarithm.
Table 3. CAC Scores (Agatston, Volume, Area, Mass, and Density) and Diameter Stenosis as Predictors of MACEs
Scores
Median (IQR) Unadjusted Model Model 1 Model 2
No Event (N=347) Event (N=46) HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
ln (Agatston), per SD 2.0 (0.7–2.4) 2.3 (1.8–2.5) 1.49 (1.07–2.07) 0.02 1.45 (0.99–2.10) 0.05 1.45 (1.00–2.10) 0.05
ln (Volume), per SD 2.0 (0.9–2.5) 2.3 (1.8–2.6) 1.50 (1.06–2.12) 0.02 1.44 (0.99–2.10) 0.06 1.46 (1.01–2.10) 0.05
ln (Area), per SD 1.9 (0.7–2.4) 2.2 (1.6–2.5) 1.44 (1.04–2.02) 0.03 1.38 (0.95–1.99) 0.09 1.39 (0.98–1.99) 0.07
ln (Mass), per SD 1.7 (0.4–2.3) 2.0 (1.4–2.3) 1.37 (1.00–1.88) 0.05 1.32 (0.93–1.87) 0.13 1.34 (0.95–1.88) 0.10
Density, per SD 2.3 (1.3–2.7) 2.6 (2.2–2.7) 1.66 (1.11–2.49) 0.01 1.70 (1.09–2.65) 0.02 1.63 (1.04–2.58) 0.03
Stenosis, per SD, % 2.2 (1.4–3.1) 3.1 (2.0–3.6) 1.93 (1.36–2.74) 0.0002 2.06 (1.23–3.43) 0.006 2.12 (1.26–3.57) 0.005
Model 1, adjusted for age, sex, and race; model 2, model 1+adjusted for statin use. CAC indicates coronary artery calcium; CI, conﬁdence interval; HR, hazard ratio; IQR, interquartile range;
ln, natural logarithm; MACE, major adverse cardiac event.
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association was no longer signiﬁcant when accounting for
CAC density in the model (Table 5). A further adjustment for
diameter stenosis yielded an estimated hazard ratio of 0.41
(95% CI, 0.19–0.87), suggesting a protective effect of
Agatston score on MACEs after adjustment, whereas calcium
density and diameter stenosis remained positively associated
with the risk of MACEs (adjusted hazard ratios, 2.62 [95% CI,
1.00–6.82] and 1.03 [95% CI, 1.01–1.05], respectively). After
excluding patients with a CAC score of 0, similar estimates
were found, except for the association between Agatston
score and MACEs, when adjusted for age, sex, and race
(hazard ratio, 1.15 [95% CI, 0.70–1.90]).
Discussion
In our international study population with symptomatic
individuals, different characteristics of CAC were measured
to investigate their associations with incident MACEs. Our
main ﬁndings are as follows: (1) Agatston score, calcium
volume score, and calcium density score are signiﬁcantly and
independently associated with risk of 2-year MACEs in a
population with suspected CAD; (2) in our symptomatic
population, CAC density is a stronger predictor than Agatston
CAC scoring for risk prediction of incident MACEs; and
(3) CAC density does not provide incremental predictive
ability beyond the Agatston score and diameter stenosis in
predicting 2-year MACEs.
This is, to our knowledge, the ﬁrst study on the indepen-
dent associations of Agatston CAC score together with
calcium volume, area, mass, and density scores of coronary
artery plaques, with incident MACEs in symptomatic patients.
More insight into these associations can be of value when
evaluating current CAC scoring systems and assessing the
role of CAC scores in coronary heart disease risk prediction
models for symptomatic patients. Although the use of CTA for
prognosis of CAD keeps evolving,22 risk prediction through
CAC scanning similarly is subject to promising developments.
In a recent study, Blaha et al found that the number of
coronary arteries with calciﬁed plaques adds signiﬁcantly to
the traditional Agatston CAC score for prediction of cardiac
events.23 With our study, we aimed to improve the ability of
traditional Agatston calcium scoring to predict cardiac events
by addressing the different characteristics of the CAC score.
Coronary calcium scanning is a well-known risk prediction
method that is widely used in asymptomatic patients. We
report that, in our symptomatic population, CAC density is
superior to traditional Agatston CAC scoring for risk predic-
tion of MACEs. Similarly, several studies have demonstrated
Table 5. Incremental Value of CAC Density and Diameter Stenosis Above Agatston Score to Predict 2-Year MACEs in
Symptomatic Patients
Variable
Model 1 Model 2 Model 3
HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
ln (Agatston), per 1 SD 1.45 (0.99–2.10) 0.05 0.82 (0.35–1.95) 0.66 0.41 (0.19–0.87) 0.02
Density, per 1 SD 2.02 (0.80–5.09) 0.14 2.62 (1.00–6.82) 0.05
Stenosis, per 1 SD, % 1.03 (1.01–1.05) 0.002
All models are adjusted for age, sex, and race. CAC indicates coronary artery calcium; CI, conﬁdence interval; HR, hazard ratio; ln, natural logarithm; MACE, major adverse
cardiac event.
Table 4. CAC Scores (Agatston, Volume, Area, Mass, and Density) and Diameter Stenosis as Predictors of MACEs in Patients With
CAC >0
Scores
Median (IQR) Unadjusted Model Model 1 Model 2
No Event (N=285) Event (N=30) HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
ln (Agatston), per SD 2.1 (1.6–2.5) 2.3 (1.8–2.5) 1.24 (0.79–1.95) 0.35 1.15 (0.70–1.90) 0.58 1.17 (0.71–1.94) 0.54
ln (Volume), per SD 2.2 (1.7–2.6) 2.3 (2.0–2.6) 1.24 (0.77–1.98) 0.37 1.12 (0.65–1.91) 0.68 1.16 (0.68–1.96) 0.59
ln (Area), per SD 2.1 (1.5–2.5) 2.2 (1.8–2.5) 1.19 (0.79–1.81) 0.41 1.09 (0.67–1.75) 0.73 1.12 (0.70–1.79) 0.64
ln (Mass), per SD 1.9 (1.2–2.4) 2.0 (1.5–2.4) 1.14 (0.78–1.67) 0.49 1.06 (0.69–1.63) 0.79 1.09 (0.71–1.66) 0.70
Density, per SD 2.4 (2.0–2.7) 2.6 (2.2–2.7) 1.45 (0.80–2.66) 0.22 1.48 (0.70–3.11) 0.30 1.40 (0.64–3.10) 0.40
Stenosis, per SD, % 2.4 (1.7–3.3) 3.1 (2.0–3.6) 1.78 (1.21–2.62) 0.004 1.89 (1.07–3.35) 0.03 1.98 (1.11–3.54) 0.02
Model 1, adjusted for age, sex, and race; model 2, model 1+adjusted for statin use. CAC indicates coronary artery calcium; CI, conﬁdence interval; HR, hazard ratio; IQR, interquartile range;
ln, natural logarithm; MACE, major adverse cardiac event.
DOI: 10.1161/JAHA.117.007201 Journal of the American Heart Association 6
CAC Scores and MACEs in Symptomatic Patients Lo-Kioeng-Shioe et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on December 5, 2019
that CAC scoring provides predictive value in symptomatic
populations.11–13 In 2012, Hou et al13 examined the prog-
nostic value of cardiac CTA and calcium score for MACEs in a
cohort that was mainly composed of symptomatic outpa-
tients. They concluded that CAC scoring is not only of
predictive value, but also has incremental value over routine
risk factors for MACEs. More recently, Nicoll et al24 studied
>5000 symptomatic patients and found that the Agatston
score is a more accurate predictor of signiﬁcant (>50%)
coronary stenosis than conventional risk factors.
Of the different CAC scores, CAC density was indepen-
dently the most predictive in our analyses. Consistent with
our data, a recently published study in patients receiving
hemodialysis by Bellasi et al reported plaque density as an
independent predictor of all-cause mortality.18
However, when comparing this ﬁnding with an asymp-
tomatic population, the MESA (Multi-Ethnic Study of
Atherosclerosis) showed an inverse association between the
calcium density of atherosclerotic plaques and risk of
cardiovascular events,17,25 indicating a protective effect of
plaques with greater calcium density. Similarly, prior studies
have shown higher CAC density in patients with stable
cardiovascular disease, compared with plaques in patients
with acute heart disease,26,27 suggesting that increased
plaque density might be a sign of stabilization of disease.
However, there are some important differences that may
explain the difference in association of CAC density with
MACEs. In the asymptomatic population studies, the deﬁnition
of MACEs included only hard outcomes (death, myocardial
infarction, and stroke), whereas in our study, we included
revascularization in the deﬁnition of MACEs. All revascular-
izations, however, were from chronic symptoms, because
acute coronary syndrome was an exclusion criterion in the
CORE320 study. This was another important difference for the
patient populations. It is plausible that less dense plaques are
more likely to rupture in otherwise asymptomatic patients,
whereas the denser plaques are more likely to be older and
associated with stable CAD symptoms, therefore more often
leading to revascularizations. This could mean that the CAC
density could be an indication of the disease stage in the
symptomatic patients. Last, the MESA investigators reported
the association between CAC density and cardiac events after
adjusting CAC density for CAC volume score, whereas in our
study, CAC density was adjusted for traditional risk factors
and statin use. This could mean that the low-density score
mainly adds predictive value in patients with smaller plaques
and, thus, that the extent of disease, reﬂected in the CAC
volume score, is leading. However, we strongly believe further
research is necessary to test these hypotheses.
Multiple studies have shown that absence of CAC is
associated with good prognosis in low-risk populations.2,4,6–9
In high-risk populations, however, a 0 calcium score may be
seen in almost 20% of patients with obstructive CAD in need
of revascularization.28 More recently, analyses within symp-
tomatic patients from CONFIRM (Coronary CT Angiography
Evaluation for Clinical Outcomes: An International Multicenter
Registry) showed that CAC absence does signiﬁcantly reduce,
but does not fully eliminate, the occurrence of obstructive
CAD.29
Our study is not without limitations. The CORE320 study
was designed as a diagnostic accuracy study and may not be
powered for this analysis and hard events in particular. Most
of our events were revascularization rather than hard events
(death, myocardial infarction, and stroke). Another potential
limitation is that the mean CAC density score was relatively
high with limited variability, leading to a high correlation
between the CAC density and the Agatston score. This could
have made it more difﬁcult to differentiate between the
scores. The association of Agatston score in this model is
clearly highly inﬂuenced by the strong positive associations
among these variables, because the association in a multi-
variable model is really the residual effect of each predictor
after adjustment for the other predictors in the model. In
particular, if each of the Agatston and density scores is
adjusted for the other, the remaining “unique contribution”
residual variables are highly negatively correlated. Given these
relationships, the protective effect of the Agatston score in
the multivariable model is highly questionable, because it is
not really an independent effect.
The results of this study support the potential of CAC
scanning for risk stratiﬁcation in symptomatic individuals.
Nevertheless, we believe cautiousness about the implications
of our conclusion is appropriate and further study in a
practical clinical trial is necessary to conﬁrm the application
of CAC scanning for this purpose. Although greater CAC
density appears to be protective in asymptomatic patients
without known CAD, greater CAC density might predict need
for revascularization in symptomatic patients. More research
into CAC scoring and the predictive value of different CAC
characteristics in symptomatic patients is essential. Compar-
ison between the Agatston score and CAC density score as
well as the inﬂuence of CAC scores when added to existing
risk scores for patients suspected of having CAD are areas
where further exploration could well be meaningful.
Conclusion
Agatston score, calcium volume score, and calcium density
score are signiﬁcant and independent predictors of incident 2-
year MACEs in symptomatic individuals, with calcium density
being superior to Agatston and calcium volume scoring.
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